Previous Blogs

Avatar

By Shari Krusniak

九月 11, 2020

West is pleased to announce the launch of our newly designed Integrated Solutions interactive webpage. After months of hard work and dedication, we are delighted to offer this dynamic page to help deliver insightful and meaningful content to our customers with an improved user experience.

Avatar

By Victoria Morgan

八月 14, 2020

In the biologics space, there are clear trends toward higher delivery volumes, less frequent dosing, and the conversion from intravenous to subcutaneous delivery. This is driving demand for wearable technologies. Read more below about the FDA’s Patient-Focused Drug Development (PFDD) Initiative and how these findings can enable more insightful patient offerings.

Avatar

By Fran DeGrazio

五月 01, 2020

The environment for developing an injectable drug device combination product (CP) is dynamic from a regulatory and technical perspective. At the center of it all are the patients and their needs. West is pleased to announce the publication of its review manuscript that provides a detailed overview of best practices for this kind of development program. It considers technical and regulatory aspects and can be used as a foundational document for drug formulators, scientists and engineers working in this area.